• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Encorium Acquisition Leads to CEO Move, COO Departure

Encorium Acquisition Leads to CEO Move, COO Departure

July 24, 2009
CenterWatch Staff

Wayne, Pa.-based contract research organization (CRO) Encorium Group has completed the sale of its U.S. business to Pierrel Research USA, a subsidiary of Italian CRO Pierrel SpA, for $2.7 million.

With the closing, Encorium announced that CEO David Ginsberg had joined Pierrel Research USA as its CEO, and chief operating officer Linda Nardone, Ph.D., has left the company. Pierrel has extended employment to most of Encorium’s U.S. employees and expects the CRO’s U.S. operations to continue largely unchanged.

Merge Healthcare also announced personnel changes as a result of its recently completed acquisition of etrials and the creation of a new division, Merge eClinical. The health IT solutions provider based in Milwaukee, Wisc., appointed Jon DeVries head of the new division. DeVries joins the company from Massachusetts General Hospital’s 3D visualization services. To align with the acquisition, Merge also announced an organization-wide staffing reduction, resulting in the elimination of 35 positions in North Carolina, Wisconsin and Ontario.

In other personnel news from the clinical trial industry:

Kendle appointed Jarrod Pontius to the position of chief legal officer, providing global leadership for all legal services, corporate governance and general corporate legal matters. Pontius was corporate counsel for Kendle from 2002 to 2007 before joining General Cable Corporation to serve as assistant general counsel.

Clinical Trials and Surveys Corp. (C-TASC) promoted Chris Donhauser to chief financial officer (CFO). Donhauser has served as executive director/treasurer to the CFO since 1999. As CFO, he will serve as the company’s top financial accountant responsible for managing C-TASC’s finances and leading client contract negotiations.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing